Mendel vs. COVID-19

Mendel has assembled a task force of 50 AI scientists, physicians and clinical experts to address COVID-19 with clinical artificial intelligence. The goal is to answer key questions and corroborate findings faster and with greater accuracy by absorbing the learnings in medical literature and cross-referencing these learnings with the electronic medical records (EMR) data of COVID-19 patients. 

Mendel’s COVID-19 search engine has the ability to parse and analyze more than 50,000 scholarly articles about coronaviruses, including the more than 50,000 articles released by the White House on COVID-19. Researchers, epidemiologists and clinicians can use this tool to ask specific questions about COVID-19 and glean relevant answers in seconds - a process that can take a human numerous hours, days, or even weeks to conduct. 

 Even existing technologies, such as Information Retrieval (IR) and out-of-the-box Natural Language Processing toolkits, fail to understand the complex clinical knowledge trapped in the literature. 

A researcher beta testing the Mendel COVID-19 search engine found evidence that Diltiazem, a drug used for hypertension, has been proven effective in halting the virus replication. Although the evidence dates back to 2006, this isn’t widely known among the scientific community today. 

This initiative is co-sponsored by our two major investors, DCM, an established  venture capital firm with a global presence, and BootstrapLabs, a venture capital firm focused exclusively on Applied AI. We’re proud to be deploying Mendel’s technology at many prominent healthcare providers across the United States, including academic and community oncology clinics as well as academic hospitals on the front lines of this pandemic. 

We are looking for partners who can accelerate the use of our technology to find effective solutions for COVID-19. If you're working to solve COVID-19, please reach out.

A researcher beta testing the Mendel COVID-19 search engine found evidence that Diltiazem, a drug used for hypertension, has been proven effective in halting the virus replication. Although the evidence dates back to 2006, this isn’t widely known among the scientific community today. 

This initiative is co-sponsored by our two major investors, DCM, an established  venture capital firm with a global presence, and BootstrapLabs, a venture capital firm focused exclusively on Applied AI. We’re proud to be deploying Mendel’s technology at many prominent healthcare providers across the United States, including academic and community oncology clinics as well as academic hospitals on the front lines of this pandemic. 

We are looking for partners who can accelerate the use of our technology to find effective solutions for COVID-19. If you're working to solve COVID-19, please reach out.

A researcher beta testing the Mendel COVID-19 search engine found evidence that Diltiazem, a drug used for hypertension, has been proven effective in halting the virus replication. Although the evidence dates back to 2006, this isn’t widely known among the scientific community today. 

This initiative is co-sponsored by our two major investors, DCM, an established  venture capital firm with a global presence, and BootstrapLabs, a venture capital firm focused exclusively on Applied AI. We’re proud to be deploying Mendel’s technology at many prominent healthcare providers across the United States, including academic and community oncology clinics as well as academic hospitals on the front lines of this pandemic. 

We are looking for partners who can accelerate the use of our technology to find effective solutions for COVID-19. If you're working to solve COVID-19, please reach out.

We are looking for partners who can accelerate the use of our technology to find effective solutions for COVID-19. If you're working to solve COVID-19, please reach out.

A researcher beta testing the Mendel COVID-19 search engine found evidence that Diltiazem, a drug used for hypertension, has been proven effective in halting the virus replication. Although the evidence dates back to 2006, this isn’t widely known among the scientific community today. 

This initiative is co-sponsored by our two major investors, DCM, an established  venture capital firm with a global presence, and BootstrapLabs, a venture capital firm focused exclusively on Applied AI. We’re proud to be deploying Mendel’s technology at many prominent healthcare providers across the United States, including academic and community oncology clinics as well as academic hospitals on the front lines of this pandemic. 

We are looking for partners who can accelerate the use of our technology to find effective solutions for COVID-19. If you're working to solve COVID-19, please reach out.

That’s why Mendel is trained to understand, not solely scan, patient medical records and clinical literature. We’ve built an engine that can be asked highly specific questions, such as, “What are the modes of transmission of a disease?,” as well as understand that “no intrauterine infections have been recorded” is a relevant answer. Mendel’s COVID-19 AI search engine extracts temporal relations, or simply put: the sequence of clinical events, by parsing a patient’s medical record without risking privacy. This approach should help predict the course of SARS- CoV as well as the outcome of different drugs and treatment approaches.

That’s why Mendel is trained to understand, not solely scan, patient medical records and clinical literature. We’ve built an engine that can be asked highly specific questions, such as, “What are the modes of transmission of a disease?,” as well as understand that “no intrauterine infections have been recorded” is a relevant answer. Mendel’s COVID-19 AI search engine extracts temporal relations, or simply put: the sequence of clinical events, by parsing a patient’s medical record without risking privacy. This approach should help predict the course of SARS- CoV as well as the outcome of different drugs and treatment approaches.

That’s why Mendel is trained to understand, not solely scan, patient medical records and clinical literature. We’ve built an engine that can be asked highly specific questions, such as, “What are the modes of transmission of a disease?,” as well as understand that “no intrauterine infections have been recorded” is a relevant answer. Mendel’s COVID-19 AI search engine extracts temporal relations, or simply put: the sequence of clinical events, by parsing a patient’s medical record without risking privacy. This approach should help predict the course of SARS- CoV as well as the outcome of different drugs and treatment approaches.

10,000

50,000

250,000

build off this: 

That’s why Mendel is trained to understand, not solely scan, patient medical records and clinical literature. We’ve built an engine that can be asked highly specific questions, such as, “What are the modes of transmission of a disease?,” as well as understand that “no intrauterine infections have been recorded” is a relevant answer. Mendel’s COVID-19 AI search engine extracts temporal relations, or simply put: the sequence of clinical events, by parsing a patient’s medical record without risking privacy. This approach should help predict the course of SARS- CoV as well as the outcome of different drugs and treatment approaches.

n/a

n/a

50+ 

Website is live. tech has been built 

15 US oncology clinics and academic centers. 

VC Backed. Establishing Product / Market Fit 

tbd

Partnerships are key to our efforts and growth. 

Spread the word!

any/open to a wide range